Compare IHS & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IHS | PRGO |
|---|---|---|
| Founded | 2001 | 1887 |
| Country | United Kingdom | Ireland |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.1B |
| IPO Year | 2021 | 1991 |
| Metric | IHS | PRGO |
|---|---|---|
| Price | $7.62 | $14.90 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | $9.32 | ★ $20.33 |
| AVG Volume (30 Days) | 1.1M | ★ 4.2M |
| Earning Date | 11-12-2025 | 02-26-2026 |
| Dividend Yield | N/A | ★ 7.70% |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.37 | N/A |
| Revenue | $1,765,825,000.00 | ★ $4,281,800,000.00 |
| Revenue This Year | $3.49 | N/A |
| Revenue Next Year | $2.77 | N/A |
| P/E Ratio | $5.88 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.02 | $12.17 |
| 52 Week High | $8.21 | $30.93 |
| Indicator | IHS | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 54.81 | 59.35 |
| Support Level | $7.34 | $13.78 |
| Resistance Level | $8.21 | $15.21 |
| Average True Range (ATR) | 0.27 | 0.40 |
| MACD | 0.02 | 0.19 |
| Stochastic Oscillator | 45.54 | 75.72 |
IHS Holding Ltd is an independent owner, operator, and developer of shared telecommunications infrastructure. The company provides telecommunications infrastructure to its customers, who are MNOs, who in turn provide wireless voice and data services to their end-users. Its geographical segments are Nigeria, Sub-Saharan Africa, the Middle East and North Africa (MENA), and Latin America (Latam). The majority of its revenue is derived from Nigeria.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.